You just read:

Eiger Announces Orphan Designation of Exendin 9-39 for Treatment of Non-Insulinoma Pancreatogenous Hypoglycemia Syndrome (NIPHS) from European Medicines Agency (EMA)

News provided by

Eiger BioPharmaceuticals, Inc.

Oct 17, 2016, 08:00 ET